Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
23
EUDA Quote, Financials, Valuation and Earnings
Last price:
$2.72
Seasonality move
:
-2.82%
Day range:
$2.72 - $3.21
52-week range:
$1.03 - $6.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
15.48x
P/B ratio:
--
Volume:
44.8K
Avg. volume:
56.5K
1-year change:
-36.6%
Market cap:
$102.7M
Revenue:
$4M
EPS (TTM):
-$0.64
Analysts' Opinion
-
Consensus RatingEUDA Health Holdings Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.00, EUDA Health Holdings Ltd. has an estimated upside of 120.59% from its current price of $2.72.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $2.72.
Fair Value
-
According to the consensus of 1 analyst, EUDA Health Holdings Ltd. has 120.59% upside to fair value with a price target of $6.00 per share.
EUDA vs. S&P 500
-
Over the past 5 trading days, EUDA Health Holdings Ltd. has underperformed the S&P 500 by -13.09% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
EUDA Health Holdings Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
EUDA Health Holdings Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter EUDA Health Holdings Ltd. reported revenues of --.
Earnings Growth
-
EUDA Health Holdings Ltd. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter EUDA Health Holdings Ltd. reported earnings per share of --.
Enterprise value:
105.8M
EV / Invested capital:
--
Price / LTM sales:
15.48x
EV / EBIT:
29.39x
EV / Revenue:
37.71x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-72.54x
Price / Operating cash flow:
39.19x
Enterprise value / EBITDA:
25.77x
Gross Profit (TTM):
-$444.2K
Return On Assets:
-344.5%
Net Income Margin (TTM):
-1319.98%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2022-12-31 | 2023-12-31 | |
| Income Statement | ||||||
| Revenue | $4.6M | $9.8M | -- | -- | -- | |
| Gross Profit | $1.3M | -- | $701.6K | -- | -- | |
| Operating Income | -$560K | -- | -- | -- | -- | |
| EBITDA | $1.9M | -- | -- | -- | -- | |
| Diluted EPS | $0.09 | -- | -$0.40 | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $4.4M | -- | -- | $762.9K | |
| Total Assets | -- | $8M | -- | -- | $1.7M | |
| Current Liabilities | -- | $7.3M | -- | -- | $4.1M | |
| Total Liabilities | -- | $7.4M | -- | -- | $4.3M | |
| Total Equity | -- | $600.1K | -- | -- | -$2.6M | |
| Total Debt | -- | $353.7K | -- | -- | $1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2022-06-30 | 2023-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$1.3M | -$3.4M | -$976.7K | -$1.7M | |
| Cash From Investing | -- | -- | -$154.5K | -$124.1K | -$1.1K | |
| Cash From Financing | -- | -- | $3.1M | $1M | $1.2M | |
| Free Cash Flow | -- | -- | -$3.4M | -$976.7K | -$1.7M | |
EUDA
Sector
Market Cap
$102.7M
$28.5M
Price % of 52-Week High
43.18%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-0.74%
-1.33%
1-Year Price Total Return
-36.6%
-20.32%
Beta (5-Year)
--
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.95
200-day SMA
Sell
Level
$3.09
Bollinger Bands (100)
Buy
Level
1.81 - 3.17
Chaikin Money Flow
Sell
Level
-26.1M
20-day SMA
Sell
Level
$2.95
Relative Strength Index (RSI14)
Sell
Level
46.98
ADX Line
Buy
Level
16.89
Williams %R
Buy
Level
-85
50-day SMA
Sell
Level
$2.72
MACD (12, 26)
Buy
Level
0.07
25-day Aroon Oscillator
Buy
Level
16
On Balance Volume
Neutral
Level
61M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-22.2974)
Sell
CA Score
(Annual)
Level (-24.5495)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (53.089)
Buy
Piotroski F Score
(Annual)
Level (5)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
EUDA Health Holdings Ltd. engages in the provision of a digital healthcare analytic platform. It operates through Medical Services and Property Management Services segments. The Medical Services segment involves in the healthcare specialty group business offering range of specialty care services to patients, and engaged in the medical facility general practice clinic that provides holistic care for various illnesses. The Property Management Services segment operates in the property management that services shopping malls, business office building, and residential apartments. The company was founded by Kelvin Chen on 2019 is headquartered in Singapore.
Stock Forecast FAQ
In the current month, EUDA has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EUDA average analyst price target in the past 3 months is $6.00.
-
Where Will EUDA Health Holdings Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that EUDA Health Holdings Ltd. share price will rise to $6.00 per share over the next 12 months.
-
What Do Analysts Say About EUDA Health Holdings Ltd.?
Analysts are divided on their view about EUDA Health Holdings Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that EUDA Health Holdings Ltd. is a Sell and believe this share price will drop from its current level to $6.00.
-
What Is EUDA Health Holdings Ltd.'s Price Target?
The price target for EUDA Health Holdings Ltd. over the next 1-year time period is forecast to be $6.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is EUDA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for EUDA Health Holdings Ltd. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of EUDA?
You can purchase shares of EUDA Health Holdings Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase EUDA Health Holdings Ltd. shares.
-
What Is The EUDA Health Holdings Ltd. Share Price Today?
EUDA Health Holdings Ltd. was last trading at $2.72 per share. This represents the most recent stock quote for EUDA Health Holdings Ltd.. Yesterday, EUDA Health Holdings Ltd. closed at $2.72 per share.
-
How To Buy EUDA Health Holdings Ltd. Stock Online?
In order to purchase EUDA Health Holdings Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get EUDA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EUDA
Sector
P/E ratio
--
23.75x
PEG ratio
0.00x
-0.01x
P/B ratio
--
1.83x
Price / LTM sales
15.48x
1.60x
Growth Metrics
EUDA
Sector
Revenue growth
--
4.85%
Earnings growth
--
11.11%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$0.02
-$0.20
Profitability
EUDA
Sector
Profitability FY 2024
$762.2K
$3.6M
Return on invested capital
--
-30.98%
Return on assets
-344.5%
-27.62%
Return on equity
--
-36.69%
Earnings Date
Last Earnings Date
Dec
8
Next Earnings Date
Dec
8
Estimated Next Earnings Date
Mar
9
Balance Sheet
EUDA
Sector
Total cash
$376.2K
$27.2M
Short term investments
--
$25.7M
Total assets
$1.7M
$79.7M
Long term debt
$2.5M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
